Suppr超能文献

对大鼠肝脏微小RNA 200a/b和429的剂量依赖性影响:肝癌发生的潜在早期生物标志物。

Dose-dependent effects on rat liver miRNAs 200a/b and 429: potential early biomarkers of liver carcinogenesis.

作者信息

Plummer S M, Wright J, Currie R A

机构信息

MicroMatrices Associates Ltd, Dundee, UK.

Syngenta Ltd, Bracknell, UK.

出版信息

Toxicol Rep. 2018 Feb 19;5:309-313. doi: 10.1016/j.toxrep.2018.02.004. eCollection 2018.

Abstract

An increased incidence of liver tumours in the long term rodent bioassay is not an uncommon finding, invariably as a result of a non-genotoxic mode of action. Non-genotoxic liver carcinogenesis has been found to involve activation of certain nuclear hormone receptors (NHR) including the constitutive androstane receptor (CAR), peroxisome proliferator activated receptor alpha (PPARalpha) and arylhydrocarbon receptor (AHR) and more recently the induction of specific microRNAs (miRs), has also been demonstrated following CAR activation in studies up to 90 days (Koufaris et al., 2012). The stable induction of these tissue specific miRs, namely miR200a, 200b and 429, by liver non-genotoxic carcinogens may serve as early predictors (biomarkers) of heptocarcinogenic potential. To test this hypothesis we used RT-PCR to measure the levels of these miRs in the livers from Wistar rats treated with two rat hepatocarcinogenic and one non hepatocarcinogenic pyrazole carboxamide succinate dehydrogenase inhibitors, Isopyrazam, Sedaxane and Benzovindiflupyr, respectively. The miRs were quantified by RT-PCR in liver RNA samples from three 90 day repeat dose toxicity studies performed at the low, mid and high doses relative to control. In Isopyrazam treated rats a statistically significant (p < 0.01) dose-dependent increase in miR 200a, 220b and 429 in both males and females was observed, whilst for Sedaxane a significant (p < 0.05) increase in miR200b in males and females at the high dose was seen. Benzovindiflupyr treatment did not cause any dose related changes in miR 200a, 200b and 429 relative to control. Our results suggest that assessment of miR 200a/200b/429 levels has potential as a biomarker of the perturbation of pathways involved in hepatocarcinogenesis in Wistar rats. Further work is required to establish the possible relationship between miR200 cluster induction and CAR-mediated hepatocarcinogenesis in a more diverse range of compounds.

摘要

在长期啮齿动物生物测定中肝脏肿瘤发病率增加并非罕见发现,这 invariably 是由于非遗传毒性作用模式导致的。已发现非遗传毒性肝脏致癌作用涉及某些核激素受体(NHR)的激活,包括组成型雄甾烷受体(CAR)、过氧化物酶体增殖物激活受体α(PPARα)和芳烃受体(AHR),最近在长达90天的研究中还证明,在CAR激活后也会诱导特定的微小RNA(miR)(Koufaris等人,2012年)。肝脏非遗传毒性致癌物对这些组织特异性miR(即miR200a、200b和429)的稳定诱导可能作为肝癌致癌潜力的早期预测指标(生物标志物)。为了验证这一假设,我们使用逆转录聚合酶链反应(RT-PCR)来测量用两种大鼠肝癌致癌物和一种非肝癌致癌的吡唑甲酰胺琥珀酸脱氢酶抑制剂(分别为异吡唑酰胺、sedaxane和苯并氟吡)处理的Wistar大鼠肝脏中这些miR的水平。通过RT-PCR对来自三项90天重复剂量毒性研究的肝脏RNA样本中的miR进行定量,这些研究在相对于对照的低、中、高剂量下进行。在异吡唑酰胺处理的大鼠中,观察到雄性和雌性miR 200a、220b和429均有统计学显著(p < 0.01)的剂量依赖性增加,而对于sedaxane,在高剂量下雄性和雌性miR200b有显著(p < 0.05)增加。相对于对照,苯并氟吡处理未导致miR 200a、200b和429有任何剂量相关变化。我们的结果表明,评估miR 200a/200b/429水平有潜力作为Wistar大鼠肝癌发生过程中相关途径扰动的生物标志物。需要进一步开展工作,以在更多种类的化合物中确定miR200簇诱导与CAR介导的肝癌发生之间的可能关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1082/5856664/55a3b54121a5/gr1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验